Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Taussig

Showing results (511-520 of 561) with videos related to

Pageof 57
Sort By:
American Journal of Respiratory and Critical Care Medicine|December 14, 2004
Late diagnosis defines a unique population of long-term survivors of cystic fibrosisDavid M Rodman, Jillian M Polis, Sonya L Heltshe, et al.
The Journal of Allergy and Clinical Immunology|December 4, 2004
Atopic characteristics of children with recurrent wheezing at high risk for the development of childhood asthmaTheresa W Guilbert, Wayne J Morgan, Robert S Zeiger, et al.
British Journal of Haematology|May 28, 2020
Venetoclax induces rapid elimination of NPM1 mutant measurable residual disease in combination with low-intensity chemotherapy in acute myeloid leukaemiaIng S Tiong, Richard Dillon, Adam Ivey, et al.
Nature Neuroscience|July 21, 2015
The role of ventral striatal cAMP signaling in stress-induced behaviorsFlorian Plattner, Kanehiro Hayashi, Adan Hernández, et al.
European Heart Journal. Digital Health|July 14, 2026
Rational and design of the digital diagnosis of cardiac sounds in paediatric patients (DI_SOUND) studyGabriele Egidy Assenza, Alessandro Colombo, Vittoria Mastromarino, et al.
The Journal of Allergy and Clinical Immunology|December 17, 2008
Impulse oscillometry versus spirometry in a long-term study of controller therapy for pediatric asthmaGary L Larsen, Wayne Morgan, Gregory P Heldt, et al.
Leukemia|August 21, 2023
Glasdegib plus intensive or non-intensive chemotherapy for untreated acute myeloid leukemia: results from the randomized, phase 3 BRIGHT AML 1019 trialMikkael A Sekeres, Pau Montesinos, Jan Novak, et al.
Journal of Medical Internet Research|October 23, 2020
A Data Visualization and Dissemination Resource to Support HIV Prevention and Care at the Local Level: Analysis and Uses of the AIDSVu Public Data ResourcePatrick Sean Sullivan, Cory Woodyatt, Chelsea Koski, et al.
British Journal of Haematology|July 8, 2024
CREST-UK: Real-world effectiveness, safety and outpatient delivery of CPX-351 for first-line treatment of newly diagnosed therapy-related AML and AML with myelodysplasia-related changes in the UKPriyanka Mehta, Victoria Campbell, Jamie Maddox, et al.
The Journal of Allergy and Clinical Immunology|October 28, 2008
Azithromycin or montelukast as inhaled corticosteroid-sparing agents in moderate-to-severe childhood asthma studyRobert C Strunk, Leonard B Bacharier, Brenda R Phillips, et al.
Pageof 57

Showing results (511-520 of 561) with videos related to

Sort By:
Pageof 57
American Journal of Respiratory and Critical Care Medicine|December 14, 2004
Late diagnosis defines a unique population of long-term survivors of cystic fibrosisDavid M Rodman, Jillian M Polis, Sonya L Heltshe, et al.
The Journal of Allergy and Clinical Immunology|December 4, 2004
Atopic characteristics of children with recurrent wheezing at high risk for the development of childhood asthmaTheresa W Guilbert, Wayne J Morgan, Robert S Zeiger, et al.
British Journal of Haematology|May 28, 2020
Venetoclax induces rapid elimination of NPM1 mutant measurable residual disease in combination with low-intensity chemotherapy in acute myeloid leukaemiaIng S Tiong, Richard Dillon, Adam Ivey, et al.
Nature Neuroscience|July 21, 2015
The role of ventral striatal cAMP signaling in stress-induced behaviorsFlorian Plattner, Kanehiro Hayashi, Adan Hernández, et al.
European Heart Journal. Digital Health|July 14, 2026
Rational and design of the digital diagnosis of cardiac sounds in paediatric patients (DI_SOUND) studyGabriele Egidy Assenza, Alessandro Colombo, Vittoria Mastromarino, et al.
The Journal of Allergy and Clinical Immunology|December 17, 2008
Impulse oscillometry versus spirometry in a long-term study of controller therapy for pediatric asthmaGary L Larsen, Wayne Morgan, Gregory P Heldt, et al.
Leukemia|August 21, 2023
Glasdegib plus intensive or non-intensive chemotherapy for untreated acute myeloid leukemia: results from the randomized, phase 3 BRIGHT AML 1019 trialMikkael A Sekeres, Pau Montesinos, Jan Novak, et al.
Journal of Medical Internet Research|October 23, 2020
A Data Visualization and Dissemination Resource to Support HIV Prevention and Care at the Local Level: Analysis and Uses of the AIDSVu Public Data ResourcePatrick Sean Sullivan, Cory Woodyatt, Chelsea Koski, et al.
British Journal of Haematology|July 8, 2024
CREST-UK: Real-world effectiveness, safety and outpatient delivery of CPX-351 for first-line treatment of newly diagnosed therapy-related AML and AML with myelodysplasia-related changes in the UKPriyanka Mehta, Victoria Campbell, Jamie Maddox, et al.
The Journal of Allergy and Clinical Immunology|October 28, 2008
Azithromycin or montelukast as inhaled corticosteroid-sparing agents in moderate-to-severe childhood asthma studyRobert C Strunk, Leonard B Bacharier, Brenda R Phillips, et al.
Pageof 57